KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Exchange Rate Effect: 2009-2024

Historic Exchange Rate Effect for Alnylam Pharmaceuticals (ALNY) over the last 8 years, with Dec 2024 value amounting to -$15.2 million.

  • Alnylam Pharmaceuticals' Exchange Rate Effect fell 106.14% to -$927,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $23.4 million, marking a year-over-year increase of 80.73%. This contributed to the annual value of -$15.2 million for FY2024, which is 338.44% down from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Exchange Rate Effect stood at -$15.2 million for FY2024, which was down 338.44% from $6.4 million recorded in FY2023.
  • Alnylam Pharmaceuticals' 5-year Exchange Rate Effect high stood at $6.4 million for FY2023, and its period low was -$15.2 million during FY2024.
  • Over the past 3 years, Alnylam Pharmaceuticals' median Exchange Rate Effect value was -$7.4 million (recorded in 2022), while the average stood at -$5.4 million.
  • In the last 5 years, Alnylam Pharmaceuticals' Exchange Rate Effect spiked by 6,025.30% in 2020 and then slumped by 338.44% in 2024.
  • Alnylam Pharmaceuticals' Exchange Rate Effect (Yearly) stood at $4.9 million in 2020, then slumped by 283.37% to -$9.0 million in 2021, then climbed by 17.61% to -$7.4 million in 2022, then spiked by 186.02% to $6.4 million in 2023, then tumbled by 338.44% to -$15.2 million in 2024.